BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Holders of 5% or more of BCDA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioCardia, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Satterfield Thomas A Jr | 13G/A | 9.90%592.1K shares | +1.70 ppfrom 8.20% | Feb 12, 20252 filings | Aug 13, 2025 | SEC |
| Lincoln Alternative Strategies LLC | 13G | 7.54%800.0K shares | New | Sep 19, 20251 filing | Sep 19, 2025 | SEC |
| Blank Andrew Scott | 13D | 5.50%278.3K shares | New | May 22, 20251 filing | May 22, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on BioCardia, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 24, 20255:13 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 4.99%557.2K shares | NewBelow 5% | Sep 18, 2025 | SEC |
| Sep 19, 20253:16 PM ET | Lincoln Alternative Strategies LLC | 13G | 7.54%800.0K shares | New | Sep 19, 2025 | SEC |
| Aug 13, 20254:05 PM ET | Satterfield Thomas A Jr | 13G/A | 9.90%592.1K shares | +1.70 ppfrom 8.20% | Jun 30, 2025 | SEC |
| May 22, 20256:18 PM ET | Blank Andrew Scott | 13D | 5.50%278.3K shares | New | Apr 23, 2025 | SEC |
| May 21, 202511:37 AM ET | Daly Joseph Patrick | 13D/A | – | – | May 14, 2025 | SEC |
| Feb 12, 20258:00 AM ET | Satterfield Thomas A Jr | 13G/A | 8.20%388.1K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BioCardia, Inc. shares.
No Form 144 notices for BioCardia, Inc. are on file.